epirubicin has been researched along with Neoplasm Metastasis, Unknown Primary in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koulentianos, E; Polyzos, A; Sfikakis, P; Tzianoumis, L | 1 |
| Bonnefoi, H; Smith, IE | 1 |
| Keefe, D; Kotasek, D; Marafioti, T; Norman, J; Olver, IN; Parnis, FX; Patterson, K; Russell, J; Taylor, A | 1 |
| Cowling, M; Harper, PG; Karapetis, CS; Ryder, K; Strickland, A; Virik, K; Yip, D | 1 |
1 trial(s) available for epirubicin and Neoplasm Metastasis, Unknown Primary
| Article | Year |
|---|---|
Phase II study of epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) for carcinoma of unknown primary site.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms, Unknown Primary; Survival Analysis; Treatment Outcome | 2000 |
3 other study(ies) available for epirubicin and Neoplasm Metastasis, Unknown Primary
| Article | Year |
|---|---|
Increased dosage of epirubicin and mitomycin-C for the treatment of metastatic adenocarcinoma of unknown primary site.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Biopsy; Dose-Response Relationship, Drug; Epirubicin; Humans; Leukopenia; Male; Mitomycin; Neoplasm Metastasis; Neoplasms, Unknown Primary; Neutropenia; Treatment Outcome | 1989 |
How should cancer presenting as a malignant pleural effusion be managed?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Carcinoma; Cisplatin; Epirubicin; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasms, Unknown Primary; Palliative Care; Pleural Effusion, Malignant; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine | 1996 |
Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil in the treatment of carcinoma of unknown primary site.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antigen; Carcinoma; Cisplatin; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms, Unknown Primary; Patient Selection; Retrospective Studies; Survival Analysis; Treatment Outcome | 2001 |